Peter Rule Email & Phone Number

Los Altos, CA, US

Sunnyvale, CA, US

Life Detection Technologies (LDT) has a unique no touch capability to measure Heart Rate and Respiration Rate. Studies show that LDT's technology is comparable to "gold standard" touch technologies in use today, and provides the additional capability to detect depth of respiration. The company is focused on the early detection of Exacerbations (lung.

• PRI is a C suite consulting firm, assisting both investors and management. Assignments range from a few days up to yearly. PRI has proven expertise in the following markets/ product categories/ physician, nursing.
• Diabetes: External and Implantable Insulin Pumps, Blood Glucose Meters, and Continuous Glucose Monitoring Systems/ Endocrinologists, Diabetes Educators.
• Drug Device Delivery: Subcutaneous Pumps, IV portable pumps/ Endocrinologists, Oncologists.
• Neuro Ischemic and Hemorrhagic Stroke: Catheter Based Technologies/ Neuro Surgeons, Neuro Interventional Radiologists.
• Cardiac Ischemia: Catheter Based Technologies/ Interventional Cardiologists, Cardiac Surgeons.
• Peripheral Vascular: Pulmonary Embolism, Deep Vein Thrombosis, and Peripheral Arterial Occlusion: Catheter Based Technologies/ Peripheral Interventional Radiologists, Vascular Surgeons.

World leader in continuous glucose monitoring for use in Intensive Care Unit medicine. Recruited by the board of directors to assess the previous direction of a non invasive glucose monitor. Redirected company to add elements sufficient to use the core technology of mid infrared glucose sensing, but with an emphasis on doing so on an automated basis, or.

London, England, GB

Leader in applying ultrasound based drug delivery for faster lysing of clot. Recruited by the board of directors during a turbulent time, to help redefine the company's direction. Redirected company from ischemic stroke to peripheral product line, requiring raising of monies, new staffing, and inventing new product line. Raised 3 rounds of financing.

World's first emboli protection company for interventional cardiology. Was one of first few employees. Established medical advisory board of world leading interventional cardiologists, and redirected product line. Conducted largest trial in interventional cardiology in history of venture backed companies (SAFER), raising ~$50M in venture capital, selling.

Leader in minimally invasive intermittent and continuous diabetic blood glucose monitoring. Raised Series A, hiring CEO, and VP, Research and Development. Identified opportunity to use company's technology for the creation of a minimally invasive and more accurate glucose meter, in addition to company's research emphasis of an interstitial fluid based.

World leader in external insulin pumps and interstitial fluid continuous glucose monitoring systems for treatment of Type 1 diabetes. Was one of first ten employees in company that went from zero revenues to $75M during this period of time. Resolved reliability issues, improved cost structure, achieved cash flow breakeven and profitability. Built.

Leader in providing miniaturized, multi channel IV pump systems for use in ICU medicine. Took over sales effort that was last in market, and became first within one year. Replaced entire sales management, and almost all of the salesforce. This was an assigned, but officer's position within Siemens, as I was "on loan" from MiniMed, at the request of the.

World leader in providing volumetrically accurate IV pump systems for hospital usage, with a focus on ICU medicine. Led project team that resulted in most successsful product introduction in IMED's history. Created sales force materials to improve sales training time. Extensive domestic and international co-traveling on current and new products. Marketing.

Bachelor Of Science - Bs, Economics

Mba